Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Empirical Formula (Hill Notation):
C14H21ClN2O3 · HCl
CAS Number:
Molecular Weight:
337.24
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
MDL number:
InChI
1S/C14H21ClN2O3.ClH/c1-4-17(5-2)6-7-20-14(18)10-8-11(15)12(16)9-13(10)19-3;/h8-9H,4-7,16H2,1-3H3;1H
SMILES string
Cl[H].CCN(CC)CCOC(=O)c1cc(Cl)c(N)cc1OC
InChI key
JOWUQCJWCRNVMQ-UHFFFAOYSA-N
form
solid
color
off-white
solubility
DMSO: 100 mg/mL, H2O: 65 mg/mL, ethanol: insoluble
originator
Sandoz
Gene Information
human ... HTR4(3360)
Biochem/physiol Actions
Potent, selective 5-HT4 serotonin receptor antagonist.
Features and Benefits
This compound was developed by Sandoz. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Storage Class
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
E F Espejo et al.
Brain research, 788(1-2), 20-24 (1998-05-21)
The role of 5-HT4 receptors on cutaneous and visceral pain remains largely unexplored. The objective of this study was to establish the activity profile of SDZ 205-557, a 5-HT4 antagonist, on cutaneous (hotplate) and visceral (writhing) models of pain, after
Y Nagakura et al.
Naunyn-Schmiedeberg's archives of pharmacology, 353(5), 489-498 (1996-04-01)
We examined the effects of exogenous 5-hydroxytryptamine (5-HT) and selective 5-HT receptor agonists and antagonists on proximal, middle and distal colonic motility in conscious fasted dogs with extraluminal force transducers implanted chronically. 5-HT (0.003-0.1 mg/kg i.v.) dose-dependently enhanced motility along
K H Buchheit et al.
Naunyn-Schmiedeberg's archives of pharmacology, 345(4), 387-393 (1992-04-01)
A selective antagonist for the recently characterized 5-HT4 receptor is lacking. The only surmountable antagonist available, ICS 205-930, is a weak antagonist and is far more potent at 5-HT3-than at 5-HT4 receptors. In this paper, SDZ 205-557 (2-methoxy-4-amino-5-chloro-benzoic acid 2-(diethylamino)
J F Kuemmerle et al.
Gastroenterology, 109(6), 1791-1800 (1995-12-01)
The type and function of 5-hydroxytryptamine (5HT) receptors on intestinal muscle cells in humans are not known. 5-HT receptors were characterized pharmacologically and by radioligand binding. Contraction, relaxation, inositol 1,4,5-triphosphate (IP3) and adenosine 3',5'-cyclic monophosphate (cAMP) formation, and 5-HT binding
J Coleman et al.
Naunyn-Schmiedeberg's archives of pharmacology, 352(1), 74-78 (1995-07-01)
A putative 5-HT4 receptor-mediated depolarization of the rat isolated vagus nerve has been studied using a grease-gap extracellular recording technique. Ondansetron (1 microM) was used to block the predominant 5-HT3 receptor mediated depolarization in this preparation and the effects of
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service